Dr Elisha Josev
Dr Elisha Josev
Contact
Available for student supervision
Dr Elisha Josev is an early career postdoctoral researcher and Senior Research Officer at the Murdoch Children's Research Institute. She holds a PhD and a Masters of Psychology (Clinical Neuropsychology) from the University of Melbourne. She also practices as a paediatric clinical neuropsychologist in neonatal medicine at the Mercy Hospital for Women, and is an Honorary Research Fellow in the Department of Paediatrics at the University of Melbourne.
Dr Josev has a special interest in the neuropsychological and neurological effects of disruption to normal brain development (particularly in children born preterm), and the impact of chronic health conditions on adolescent brain functioning and behaviour.
She currently coordinates a paediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research program at MCRI as principal investigator on a world-first longitudinal neuroimaging project in paediatric ME/CFS, and also leads the paediatric component of Australia’s first ME/CFS biobank. She is also chief investigator on an NHMRC-funded study investigating pathophysiological mechanisms underlying paediatric ME/CFS.
Other Affiliations:
· Honorary Research Fellow, Department of Paediatrics, University of Melbourne
· Paediatric Clinical Neuropsychologist, Mercy Hospital for Women
Dr Josev has a special interest in the neuropsychological and neurological effects of disruption to normal brain development (particularly in children born preterm), and the impact of chronic health conditions on adolescent brain functioning and behaviour.
She currently coordinates a paediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research program at MCRI as principal investigator on a world-first longitudinal neuroimaging project in paediatric ME/CFS, and also leads the paediatric component of Australia’s first ME/CFS biobank. She is also chief investigator on an NHMRC-funded study investigating pathophysiological mechanisms underlying paediatric ME/CFS.
Other Affiliations:
· Honorary Research Fellow, Department of Paediatrics, University of Melbourne
· Paediatric Clinical Neuropsychologist, Mercy Hospital for Women
Dr Elisha Josev is an early career postdoctoral researcher and Senior Research Officer at the Murdoch Children's Research Institute. She holds a PhD and a Masters of Psychology (Clinical Neuropsychology) from the University of Melbourne. She also...
Dr Elisha Josev is an early career postdoctoral researcher and Senior Research Officer at the Murdoch Children's Research Institute. She holds a PhD and a Masters of Psychology (Clinical Neuropsychology) from the University of Melbourne. She also practices as a paediatric clinical neuropsychologist in neonatal medicine at the Mercy Hospital for Women, and is an Honorary Research Fellow in the Department of Paediatrics at the University of Melbourne.
Dr Josev has a special interest in the neuropsychological and neurological effects of disruption to normal brain development (particularly in children born preterm), and the impact of chronic health conditions on adolescent brain functioning and behaviour.
She currently coordinates a paediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research program at MCRI as principal investigator on a world-first longitudinal neuroimaging project in paediatric ME/CFS, and also leads the paediatric component of Australia’s first ME/CFS biobank. She is also chief investigator on an NHMRC-funded study investigating pathophysiological mechanisms underlying paediatric ME/CFS.
Other Affiliations:
· Honorary Research Fellow, Department of Paediatrics, University of Melbourne
· Paediatric Clinical Neuropsychologist, Mercy Hospital for Women
Dr Josev has a special interest in the neuropsychological and neurological effects of disruption to normal brain development (particularly in children born preterm), and the impact of chronic health conditions on adolescent brain functioning and behaviour.
She currently coordinates a paediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research program at MCRI as principal investigator on a world-first longitudinal neuroimaging project in paediatric ME/CFS, and also leads the paediatric component of Australia’s first ME/CFS biobank. She is also chief investigator on an NHMRC-funded study investigating pathophysiological mechanisms underlying paediatric ME/CFS.
Other Affiliations:
· Honorary Research Fellow, Department of Paediatrics, University of Melbourne
· Paediatric Clinical Neuropsychologist, Mercy Hospital for Women
Top Publications
- Thomas, N, Chau, T, Tantanis, D, Huang, K, Scheinberg, A, Gooley, PR, Josev, EK, Knight, SJ, Armstrong, CW. Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatric myalgic encephalomyelitis/chronic fatigue syndrome in Australian adolescents aged 12-19 years.. BMJ Open 14(12) : e089038 2024 view publication
- Rawnsley, KL, Doyle, LW, Anderson, PJ, Olsen, JE, Kwong, AKL, Mainzer, RM, Josev, EK, Roberts, G, Spittle, AJ, Cheong, JLY. Parent screening questionnaires to detect cognitive and language delay at 2 years in high-risk infants: an analysis from the Victorian Infant Collaborative Study 2016-2017 cohort.. Arch Dis Child Fetal Neonatal Ed 109(6) : 652 -656 2024 view publication
- Byrne, H, Knight, SJ, Josev, EK, Scheinberg, A, Beare, R, Yang, JYM, Oldham, S, Rowe, K, Seal, ML. Hypothalamus Connectivity in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.. J Neurosci Res 102(10) : e25392 2024 view publication
- Annesley, SJ, Missailidis, D, Heng, B, Josev, EK, Armstrong, CW. Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies.. Trends Mol Med 30(5) : 443 -458 2024 view publication
- Byrne, H, Josev, EK, Knight, SJ, Scheinberg, A, Rowe, K, Lubitz, L, Seal, ML. Hypothalamus volumes in adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact of self-reported fatigue and illness duration. 2024 view publication
Page 1 of 8